Literature DB >> 34369881

Low serum corin levels predict end-organ damage in patients with hypertensive crisis.

Burcu Genç Yavuz1, Özgür Söğüt2, Şahin Çolak1, Macit Koldaş3, Esma Yücetaş3, Okan Bari2.   

Abstract

OBJECTIVE: The study aimed to investigate the predictive power of serum corin levels for distinguishing between hypertensive urgency (HU) and hypertensive emergency (HE) in patients with hypertensive crisis (HC) admitted to the emergency department.
METHODS: A total of 120 consecutive consenting adult patients diagnosed with HC and 55 age- and sex-matched healthy controls were enrolled. Blood pressure measurements [(systolic, diastolic, and mean arterial pressure (MAP)] and the evidence of end-organ damage at the first admission were recorded. Patients with HC were classified as patients with HE or HU according to the presence or absence of acute end-organ damage. Serum corin levels were compared between the 2 groups.
RESULTS: The mean serum corin level was significantly lower in the HC group than in the control group; it was also lower in the HE group than in the HU group (p<0.001 for all). In the HE group, clinical features associated with end-organ damage included ST-elevation myocardial infarction (n=28, 46.7%), hemorrhagic stroke (n=11, 18.3%), ischemic stroke (n=11, 18.3%), and non-ST-elevation myocardial infarction (n=10, 16.7%). The receiving operator characteristic (ROC) analysis identified a serum corin cutoff value of 45 pg/mL for distinguishing patients with HE from patients with HU with 98.3% sensitivity and 95% specificity.
CONCLUSION: Our findings suggest that serum corin levels play an important role in regulating blood pressure and are involved in the pathogenesis of HC. Low serum corin levels may predict end-organ damage and serve as a guide for diagnostic decision making in patients with HC.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34369881      PMCID: PMC8357442          DOI: 10.5152/AnatolJCardiol.2021.06698

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


  33 in total

1.  Association Between High Serum Soluble Corin and Hypertension: A Cross-Sectional Study in a General Population of China.

Authors:  Hao Peng; Qiu Zhang; Xiaoqin Cai; Yan Liu; Jiansong Ding; Honggang Tian; Xiangqin Chao; Hengshan Shen; Li Jiang; Jianhua Jin; Yonghong Zhang
Journal:  Am J Hypertens       Date:  2015-02-07       Impact factor: 2.689

2.  Treatment of hypertensive emergencies.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-05

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Frequency of serious outcomes in patients with hypertension as a chief complaint in the emergency department.

Authors:  Steven P Frei; David B Burmeister; Jesse F Coil
Journal:  J Am Osteopath Assoc       Date:  2013-09

5.  Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.

Authors:  Joyce C Y Chan; Ole Knudson; Faye Wu; John Morser; William P Dole; Qingyu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-06       Impact factor: 11.205

6.  Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort.

Authors:  Phillip D Levy; James J Mahn; Joseph Miller; Alicia Shelby; Aaron Brody; Russell Davidson; Michael J Burla; Alexander Marinica; Justin Carroll; John Purakal; John M Flack; Robert D Welch
Journal:  Am J Emerg Med       Date:  2015-05-30       Impact factor: 2.469

Review 7.  Management of hypertensive crises.

Authors:  R W Gifford
Journal:  JAMA       Date:  1991-08-14       Impact factor: 56.272

Review 8.  Corin: new insights into the natriuretic peptide system.

Authors:  Qingyu Wu; Ye Olivia Xu-Cai; Shenghan Chen; Wei Wang
Journal:  Kidney Int       Date:  2008-08-20       Impact factor: 10.612

9.  Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome.

Authors:  Aviva Peleg; Diab Ghanim; Shiraz Vered; Yonathan Hasin
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

10.  2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group.

Authors:  F Arslan; L Bongartz; J M Ten Berg; J W Jukema; Y Appelman; A H Liem; R J de Winter; A W J van 't Hof; P Damman
Journal:  Neth Heart J       Date:  2018-09       Impact factor: 2.380

View more
  1 in total

Review 1.  Corin: A Key Mediator in Sodium Homeostasis, Vascular Remodeling, and Heart Failure.

Authors:  Xianrui Zhang; Xiabing Gu; Yikai Zhang; Ningzheng Dong; Qingyu Wu
Journal:  Biology (Basel)       Date:  2022-05-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.